Skip to main content
SpringerLink
Log in

Percutaneous Image-Guided Interventions Including Solid Organ Biopsies

  • Chapter
  • First Online:
Management of Bleeding Patients

  • 1489 Accesses

Abstract

Management of bleeding in patients undergoing interventional procedures is complex owing to the wide range of comorbidities and anticoagulants currently involved in patient care. The field is further complicated by a paucity of data providing guidelines on how to manage patients’ bleeding risks. Many studies used to guide bleeding management are provided by surgical literature; however, interventional procedures differ from open invasive procedures by the inability to see and directly control sources of bleeding during the procedures. Complications related to bleeding from interventional procedures are often delayed. It is therefore important to reduce the pre-procedural risk when performing interventional procedures. This chapter details current literature on the management of bleeding risk with various anticoagulants. Guidelines for specific interventional procedures are also discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Patel IJ, Davidson JC, Nikolic B, Salazar GM, Schwartzberg MS, Walker TG, et al. Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol. 2012;23(6):727–36.

    Article  PubMed  Google Scholar 

  2. Hibbs SP, McKechnie S, Little M, Uberoi R, Desborough MJ. Peri-procedural management of bleeding risks in critical care patients: a local audit and national survey. J Intens Care Soc. 2014;16:99–104. doi:10.1177/1751143714559903.

    Article  Google Scholar 

  3. Godfrey EM, Godfrey AL, Perry DJ, Shaw AS. Don’t be a clot: a radiologist's guide to haemostasis including novel antiplatelet and anticoagulant therapies. Clin Radiol. 2011;66(8):693–700.

    Article  CAS  PubMed  Google Scholar 

  4. Schenone M, Furie BC, Furie B. The blood coagulation cascade. Curr Opin Hematol. 2004;11(4):272–7.

    Article  CAS  PubMed  Google Scholar 

  5. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97(2):439–45.

    Article  PubMed  Google Scholar 

  6. Pilsczek FH, Rifkin WD, Walerstein S. Overuse of prothrombin and partial thromboplastin coagulation tests in medical inpatients. Heart Lung. 2005;34(6):402–5.

    Article  PubMed  Google Scholar 

  7. Kitchens CS. To bleed or not to bleed? Is that the question for the PTT? J Thromb Haemost. 2005;3(12):2607–11.

    Article  CAS  PubMed  Google Scholar 

  8. Greinacher A, Selleng K. Thrombocytopenia in the intensive care unit patient. Hematology Am Soc Hematol Educ Program. 2010;2010:135–43.

    PubMed  Google Scholar 

  9. British Committee for Standards in Haematology, Blood Transfusion Task Force. Guidelines for the use of platelet transfusions. Br J Haematol. 2003;122(1):10–23.

    Article  Google Scholar 

  10. Altenburg A, Haage P. Antiplatelet and anticoagulant drugs in interventional radiology. Cardiovasc Intervent Radiol. 2012;35(1):30–42.

    Article  PubMed  Google Scholar 

  11. Hirsh J, Dalen JE, Anderson DR, Poller L, Bussey H, Ansell J, et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest. 2001;119(1 Suppl):8S–21.

    Article  CAS  PubMed  Google Scholar 

  12. Escobar MA. Reversal of coumarin‐induced over‐anticoagulation. Br J Haematol. 2002;118(3):925–6.

    PubMed  Google Scholar 

  13. Stanworth SJ. The evidence-based use of FFP and cryoprecipitate for abnormalities of coagulation tests and clinical coagulopathy. Hematology Am Soc Hematol Educ Program. 2007:179–86

    Google Scholar 

  14. Stanworth SJ, Brunskill SJ, Hyde CJ, McClelland DB, Murphy MF. Is fresh frozen plasma clinically effective? A systematic review of randomized controlled trials. Br J Haematol. 2004;126(1):139–52.

    Article  CAS  PubMed  Google Scholar 

  15. Wahi R, Hoppensteadt D. Management of bleeding in urgent interventions. Urg Int Ther. 2014:66–76.

    Google Scholar 

  16. Ansell J, Hirsh J, Poller L, Bussey H, Jacobson A, Hylek E. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3 Suppl):204s–33.

    Article  CAS  PubMed  Google Scholar 

  17. Raj G, Kumar R, McKinney WP. Time course of reversal of anticoagulant effect of warfarin by intravenous and subcutaneous phytonadione. Arch Intern Med. 1999;159(22):2721–4.

    Article  CAS  PubMed  Google Scholar 

  18. McAvoy TJ. The biologic half-life of heparin. Clin Pharmacol Ther. 1979;25(3):372–9.

    Article  CAS  PubMed  Google Scholar 

  19. Butterworth J, Lin YA, Prielipp R, Bennett J, James R. The pharmacokinetics and cardiovascular effects of a single intravenous dose of protamine in normal volunteers. Anesth Analg. 2002;94(3):514–22. table of contents.

    Article  CAS  PubMed  Google Scholar 

  20. Butterworth J, Lin YA, Prielipp RC, Bennett J, Hammon JW, James RL. Rapid disappearance of protamine in adults undergoing cardiac operation with cardiopulmonary bypass. Ann Thorac Surg. 2002;74(5):1589–95.

    Article  PubMed  Google Scholar 

  21. Turpie AG, Eriksson BI, Lassen MR, Bauer KA. Fondaparinux, the first selective factor Xa inhibitor. Curr Opin Hematol. 2003;10(5):327–32.

    Article  PubMed  Google Scholar 

  22. Warkentin TE. Fondaparinux: does it cause HIT? Can it treat HIT? Expert Rev Hematol. 2010;3(5):567–81.

    Article  CAS  PubMed  Google Scholar 

  23. Di Nisio M, Middeldorp S, Buller HR. Direct thrombin inhibitors. N Engl J Med. 2005;353(10):1028–40.

    Article  PubMed  Google Scholar 

  24. van Ryn J, Stangier J, Haertter S, Liesenfeld KH, Wienen W, Feuring M, et al. Dabigatran etexilate—a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity. Thromb Haemost. 2010;103(6):1116–27.

    Article  PubMed  Google Scholar 

  25. Wong PC, Pinto DJ, Zhang D. Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor. J Thromb Thrombolysis. 2011;31(4):478–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Gonsalves WI, Gupta V, Patnaik MM. Management of bleeding complications in patients with new oral anticoagulants. J Hematol Transfus. 2014;2(1):1015.

    Google Scholar 

  27. Pernod G, Albaladejo P, Godier A, Samama CM, Susen S, Gruel Y, et al. Management of major bleeding complications and emergency surgery in patients on long-term treatment with direct oral anticoagulants, thrombin or factor-Xa inhibitors: proposals of the working group on perioperative haemostasis (GIHP)–March 2013. Arch Cardiovasc Dis. 2013;106(6):382–93.

    Article  PubMed  Google Scholar 

  28. Eerenberg ES, Kamphuisen PW, Sijpkens MK, Meijers JC, Buller HR, Levi M. Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate a randomized, placebo-controlled, crossover study in healthy subjects. Circulation. 2011;124(14):1573–9.

    Article  CAS  PubMed  Google Scholar 

  29. Baumann Kreuziger LM, Keenan JC, Morton CT, Dries DJ. Management of the bleeding patient receiving new oral anticoagulants: a role for prothrombin complex concentrates. Biomed Res Int. 2014;2014:583794.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  30. Baumann Kreuziger LM, Reding MT. Management of bleeding associated with dabigatran and rivaroxaban: a survey of current practices. Thromb Res. 2013;132(2):e161–3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Marlu R, Hodaj E, Paris A, Albaladejo P, Cracowski JL, Pernod G. Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers. Thromb Haemost. 2012;108(2):217–24.

    Article  CAS  PubMed  Google Scholar 

  32. Pusateri AE, Park MS. Mechanistic implications for the use and monitoring of recombinant activated factor VII in trauma. Crit Care. 2005;9 Suppl 5:S15–24.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Scharrer I. Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency. Haemophilia. 1999;5(4):253–9.

    Article  CAS  PubMed  Google Scholar 

  34. Golan DE, Tashjian AH, Armstrong EJ. Principles of pharmacology: the pathophysiologic basis of drug therapy. Philadelphia: Lippincott Williams & Wilkins; 2011.

    Google Scholar 

  35. Atwell TD, Smith RL, Hesley GK, Callstrom MR, Schleck CD, Harmsen WS, et al. Incidence of bleeding after 15,181 percutaneous biopsies and the role of aspirin. Am J Roentgenol. 2010;194(3):784–9.

    Article  Google Scholar 

  36. Hussain N, Alsulaiman R, Burtin P, Toubouti Y, Rahme E, Boivin JF, et al. The safety of endoscopic sphincterotomy in patients receiving antiplatelet agents: a case-control study. Aliment Pharmacol Ther. 2007;25(5):579–84.

    Article  CAS  PubMed  Google Scholar 

  37. Fox KA, Mehta SR, Peters R, Zhao F, Lakkis N, Gersh BJ, et al. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial. Circulation. 2004;110(10):1202–8.

    Article  CAS  PubMed  Google Scholar 

  38. Chassot PG, Delabays A, Spahn DR. Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction. Br J Anaesth. 2007;99(3):316–28.

    Article  CAS  PubMed  Google Scholar 

  39. Mannucci PM, Remuzzi G, Pusineri F, Lombardi R, Valsecchi C, Mecca G, et al. Deamino-8-D-arginine vasopressin shortens the bleeding time in uremia. N Engl J Med. 1983;308(1):8–12.

    Article  CAS  PubMed  Google Scholar 

  40. Lippi G, Montagnana M, Danese E, Favaloro EJ, Franchini M. Glycoprotein IIb/IIIa inhibitors: an update on the mechanism of action and use of functional testing methods to assess antiplatelet efficacy. Biomark Med. 2011;5(1):63–70.

    Article  CAS  PubMed  Google Scholar 

  41. Patel IJ, Davidson JC, Nikolic B, Salazar GM, Schwartzberg MS, Walker TG, et al. Addendum of newer anticoagulants to the SIR consensus guideline. J Vasc Interv Radiol. 2013;24(5):641–5.

    Article  PubMed  Google Scholar 

  42. Schafer AI. Effects of nonsteroidal antiinflammatory drugs on platelet function and systemic hemostasis. J Clin Pharmacol. 1995;35(3):209–19.

    Article  CAS  PubMed  Google Scholar 

  43. Schafer AI. Effects of nonsteroidal anti-inflammatory therapy on platelets. Am J Med. 1999;106(5b):25s–36.

    Article  CAS  PubMed  Google Scholar 

  44. Kennedy SA, Milovanovic L, Midia M. Major bleeding after percutaneous image-guided biopsies: frequency, predictors, and periprocedural management. Semin Interv Radiol. 2015;32:26–33.

    Article  Google Scholar 

  45. Nakamoto DA, Wilkins LR, Haaga JR. Hemostasis effects of direct intraparenchymal injection of platelets and fresh frozen plasma before cutting needle biopsy in an animal model. J Vasc Interv Radiol. 2011;22(11):1601–5.

    Article  PubMed  Google Scholar 

  46. Wong P, Johnson KJ, Warner RL, Merz SI, Kruger GH, Weitzel WF. Performance of biopsy needle with therapeutic injection system to prevent bleeding complications. J Med Device. 2013;7(1):011002.

    Article  Google Scholar 

  47. Dauerman HL, Applegate RJ, Cohen DJ. Vascular closure devices: the second decade. J Am Coll Cardiol. 2007;50(17):1617–26.

    Article  PubMed  Google Scholar 

  48. Wang DS, Chu LF, Olson SE, Miller FJ, Valji K, Wong WH, et al. Comparative evaluation of noninvasive compression adjuncts for hemostasis in percutaneous arterial, venous, and arteriovenous dialysis access procedures. J Vasc Interv Radiol. 2008;19(1):72–9.

    Article  PubMed  Google Scholar 

  49. Sesana M, Vaghetti M, Albiero R, Corvaja N, Martini G, Sivieri G, et al. Effectiveness and complications of vascular access closure devices after interventional procedures. J Invasive Cardiol. 2000;12(8):395–9.

    CAS  PubMed  Google Scholar 

  50. Darcy MD, Kanterman RY, Kleinhoffer MA, Vesely TM, Picus D, Hicks ME, et al. Evaluation of coagulation tests as predictors of angiographic bleeding complications. Radiology. 1996;198(3):741–4.

    Article  CAS  PubMed  Google Scholar 

  51. Barsuk JH, Cohen ER, Feinglass J, McGaghie WC, Wayne DB. Clinical outcomes after bedside and interventional radiology paracentesis procedures. Am J Med. 2013;126(4):349–56.

    Article  PubMed  Google Scholar 

  52. Runyon BA. Management of adult patients with ascites due to cirrhosis: an update. Hepatology. 2009;49(6):2087–107.

    Article  PubMed  Google Scholar 

  53. Puchalski JT, Argento AC, Murphy TE, Araujo KL, Pisani MA. The safety of thoracentesis in patients with uncorrected bleeding risk. Ann Am Thorac Soc. 2013;10(4):336–41.

    Article  PubMed  PubMed Central  Google Scholar 

  54. Whittier WL. Complications of the percutaneous kidney biopsy. Adv Chronic Kidney Dis. 2012;19(3):179–87.

    Article  PubMed  Google Scholar 

  55. Whittier WL, Korbet S. Indications for and complications of renal biopsy. UpToDate. 2012;20(4).

    Google Scholar 

  56. Whittier WL, Korbet SM. Timing of complications in percutaneous renal biopsy. J Am Soc Nephrol. 2004;15(1):142–7.

    Article  PubMed  Google Scholar 

  57. Renal Physicians Association. RPA position on optimal length of observation after percutaneous renal biopsy. Clin Nephrol. 2001;56(2):179–80.

    Google Scholar 

  58. Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH, et al. Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e326S–50.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  59. Shidham GB, Siddiqi N, Beres JA, Logan B, Nagaraja HN, Shidham SG, et al. Clinical risk factors associated with bleeding after native kidney biopsy. Nephrology. 2005;10(3):305–10.

    Article  PubMed  Google Scholar 

  60. Kohli HS, Jairam A, Bhat A, Sud K, Jha V, Gupta KL, et al. Safety of kidney biopsy in elderly: a prospective study. Int Urol Nephrol. 2006;38(3–4):815–20.

    PubMed  Google Scholar 

  61. Zhu M, Chen J, Xu A. Factors that can minimize bleeding complications after renal biopsy. Int Urol Nephrol. 2014;46(10):1969–75.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Martin JH, Rosser CJ, Linebach RF, McCullough DL, Assimos DG. Are coagulation studies necessary before percutaneous nephrostomy? Tech Urol. 2000;6(3):205–7.

    CAS  PubMed  Google Scholar 

  63. Mackinnon B, Fraser E, Simpson K, Fox JG, Geddes C. Is it necessary to stop antiplatelet agents before a native renal biopsy? Nephrol Dial Transplant. 2008;23(11):3566–70.

    Article  CAS  PubMed  Google Scholar 

  64. van den Hoogen MW, Verbruggen BW, Polenewen R, Hilbrands LB, Nováková IR. Use of the platelet function analyzer to minimize bleeding complications after renal biopsy. Thromb Res. 2009;123(3):515–22.

    Article  PubMed  CAS  Google Scholar 

  65. Ranghino A, Mella A, Borchiellini A, Nappo A, Manzione A, Gallo E, et al. Assessment of platelet function analyzer (PFA-100) in kidney transplant patients before renal allograft biopsy: a retrospective single-center analysis. Transplant Proc. 2014;46:2259–62. Elsevier.

    Article  CAS  PubMed  Google Scholar 

  66. Manno C, Bonifati C, Torres DD, Campobasso N, Schena FP. Desmopressin acetate in percutaneous ultrasound-guided kidney biopsy: a randomized controlled trial. Am J Kidney Dis. 2011;57(6):850–5.

    Article  CAS  PubMed  Google Scholar 

  67. Vigano GL, Mannucci PM, Lattuada A, Harris A, Remuzzi G. Subcutaneous desmopressin (DDAVP) shortens the bleeding time in uremia. Am J Hematol. 1989;31(1):32–5.

    Article  CAS  PubMed  Google Scholar 

  68. McVay PA, Toy PT. Lack of increased bleeding after liver biopsy in patients with mild hemostatic abnormalities. Am J Clin Pathol. 1990;94(6):747–53.

    Article  CAS  PubMed  Google Scholar 

  69. Wallace MJ, Narvios A, Lichtiger B, Ahrar K, Morello Jr FA, Gupta S, et al. Transjugular liver biopsy in patients with hematologic malignancy and severe thrombocytopenia. J Vasc Interv Radiol. 2003;14(3):323–7.

    Article  PubMed  Google Scholar 

  70. Elbich J, Khetarpal A, Gabriel R, Sok M, Sydnor M. Transjugular liver biopsy: correlation of bleeding complications to INR values in 613 consecutive patients. J Vasc Interv Radiol. 2015;26(2):S83.

    Article  Google Scholar 

  71. Solbiati L, Livraghi T, De Pra L, Ierace T, Masciadri N, Ravetto C. Fine-needle biopsy of hepatic hemangioma with sonographic guidance. Am J Roentgenol. 1985;144(3):471–4.

    Article  CAS  Google Scholar 

  72. van Beek D, Funaki B. Hemorrhage as a complication of percutaneous liver biopsy. Semin Interv Radiol. 2013;30:413–6. Thieme Medical Publishers.

    Article  Google Scholar 

  73. Wu CC, Maher MM, Shepard JA. Complications of CT-guided percutaneous needle biopsy of the chest: prevention and management. Am J Roentgenol. 2011;196(6):W678–82.

    Article  Google Scholar 

  74. Yeow KM, Su IH, Pan KT, Tsay PK, Lui KW, Cheung YC, et al. Risk factors of pneumothorax and bleeding: multivariate analysis of 660 CT-guided coaxial cutting needle lung biopsies. Chest. 2004;126(3):748–54.

    Article  PubMed  Google Scholar 

  75. Winokur RS, Pua BB, Sullivan BW, Madoff DC. Percutaneous lung biopsy: technique, efficacy, and complications. Semin Interv Radiol. 2013;30(2):121–7.

    Article  Google Scholar 

  76. Somerville P, Seifert PJ, Destounis SV, Murphy PF, Young W. Anticoagulation and bleeding risk after core needle biopsy. Am J Roentgenol. 2008;191(4):1194–7.

    Article  Google Scholar 

  77. Chetlen AL, Kasales C, Mack J, Schetter S, Zhu J. Hematoma formation during breast core needle biopsy in women taking antithrombotic therapy. Am J Roentgenol. 2013;201(1):215–22.

    Article  Google Scholar 

  78. Melotti MK, Berg WA. Core needle breast biopsy in patients undergoing anticoagulation therapy: preliminary results. Am J Roentgenol. 2000;174(1):245–9.

    Article  CAS  Google Scholar 

  79. Vats HS. Complications of catheters: tunneled and nontunneled. Adv Chronic Kidney Dis. 2012;19(3):188–94.

    Article  PubMed  Google Scholar 

  80. Vinson DR, Ballard DW, Hance LG, Hung Y, Rauchwerger AS, Reed ME, et al. Bleeding complications of central venous catheterization in septic patients with abnormal hemostasis. Am J Emerg Med. 2014;32(7):737–42.

    Article  PubMed  Google Scholar 

  81. Rabindranath KS, Kumar E, Shail R, Vaux E. Use of real-time ultrasound guidance for the placement of hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials. Am J Kidney Dis. 2011;58(6):964–70.

    Article  PubMed  Google Scholar 

  82. Cavanna L, Civardi G, Mordenti P, Vallisa D, Berte R, Di Nunzio C. Central venous catheter care for the patients with cancer: ultrasound-guided insertion should be strongly recommended for internal jugular vein catheterization. Ann Oncol. 2013;24(11):2928–9.

    Article  CAS  PubMed  Google Scholar 

  83. Cavanna L, Civardi G, Vallisa D, Di Nunzio C, Cappucciati L, Berte R, et al. Ultrasound-guided central venous catheterization in cancer patients improves the success rate of cannulation and reduces mechanical complications: a prospective observational study of 1,978 consecutive catheterizations. World J Surg Oncol. 2010;8:91.

    Article  PubMed  PubMed Central  Google Scholar 

  84. Haas B, Chittams JL, Trerotola SO. Large-bore tunneled central venous catheter insertion in patients with coagulopathy. J Vasc Interv Radiol. 2010;21(2):212–7.

    Article  PubMed  Google Scholar 

  85. Mumtaz H, Williams V, Hauer-Jensen M, Rowe M, Henry-Tillman RS, Heaton K, et al. Central venous catheter placement in patients with disorders of hemostasis. Am J Surg. 2000;180(6):503–5. discussion 6.

    Article  CAS  PubMed  Google Scholar 

  86. Fisher NC, Mutimer DJ. Central venous cannulation in patients with liver disease and coagulopathy—a prospective audit. Intensive Care Med. 1999;25(5):481–5.

    Article  CAS  PubMed  Google Scholar 

  87. Frykholm P, Pikwer A, Hammarskjöld F, Larsson A, Lindgren S, Lindwall R, et al. Clinical guidelines on central venous catheterisation. Acta Anaesthesiol Scand. 2014;58(5):508–24.

    Article  CAS  PubMed  Google Scholar 

  88. Morado M, Jimenez-Yuste V, Villar A, Quintana M, Del Castillo F, Garzon G, et al. Complications of central venous catheters in patients with haemophilia and inhibitors. Haemophilia. 2001;7(6):551–6.

    Article  CAS  PubMed  Google Scholar 

  89. Stecker MS, Johnson MS, Ying J, McLennan G, Agarwal DM, Namyslowski J, et al. Time to hemostasis after traction removal of tunneled cuffed central venous catheters. J Vasc Interv Radiol. 2007;18(10):1232–9. quiz 40.

    Article  PubMed  Google Scholar 

  90. Raj PP, Shah RV, Kaye AD, Denaro S, Hoover JM. Bleeding risk in interventional pain practice: assessment, management, and review of the literature. Pain Physician. 2004;7(1):3–51.

    PubMed  Google Scholar 

  91. Manchikanti L, Malla Y, Wargo BW, Cash KA, McManus CD, Damron KS, et al. A prospective evaluation of bleeding risk of interventional techniques in chronic pain. Pain Physician. 2011;14(4):317–29.

    PubMed  Google Scholar 

  92. Horlocker TT, Wedel DJ, Offord KP. Does preoperative antiplatelet therapy increase the risk of hemorrhagic complications associated with regional anesthesia? Anesth Analg. 1990;70(6):631–4.

    Article  CAS  PubMed  Google Scholar 

  93. Horlocker TT, Wedel DJ, Schroeder DR, Rose SH, Elliott BA, McGregor DG, et al. Preoperative antiplatelet therapy does not increase the risk of spinal hematoma associated with regional anesthesia. Anesth Analg. 1995;80(2):303–9.

    CAS  PubMed  Google Scholar 

  94. Horlocker TT, Bajwa Z, Ashraf Z, et al. Risk assessment of hemorrhagic complications associated with nonsteroidal antiinflammatory medications in ambulatory pain clinic patients undergoing epidural steroid injection. Anesth Analg. 2002;95:1691–7.

    Article  CAS  PubMed  Google Scholar 

  95. Horlocker TT, Wedel DJ, Rowlingson JC, Enneking FK, Kopp SL, Benzon HT, et al. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy: American Society of Regional Anesthesia and Pain Medicine Evidence-Based Guidelines (Third Edition). Reg Anesth Pain Med. 2010;35(1):64–101.

    Article  CAS  PubMed  Google Scholar 

  96. Manchikanti L, Falco F, Benyamin R, Caraway D, Kaye A, Helm 2nd S, et al. Assessment of bleeding risk of interventional techniques: a best evidence synthesis of practice patterns and perioperative management of anticoagulant and antithrombotic therapy. Pain Physician. 2013;16(2 Suppl):SE261–318.

    PubMed  Google Scholar 

  97. Edelson RN, Chernik NL, Posner JB. Spinal subdural hematomas complicating lumbar puncture. Arch Neurol. 1974;31(2):134–7.

    Article  CAS  PubMed  Google Scholar 

  98. Breuer AC, Tyler HR, Marzewski DJ, Rosenthal DS. Radicular vessels are the most probable source of needle-induced blood in lumbar puncture: significance for the thrombocytopenic cancer patient. Cancer. 1982;49(10):2168–72.

    Article  CAS  PubMed  Google Scholar 

  99. Howard SC, Gajjar A, Ribeiro RC, Rivera GK, Rubnitz JE, Sandlund JT, et al. Safety of lumbar puncture for children with acute lymphoblastic leukemia and thrombocytopenia. JAMA. 2000;284(17):2222–4.

    Article  CAS  PubMed  Google Scholar 

  100. Vavricka SR, Walter RB, Irani S, Halter J, Schanz U. Safety of lumbar puncture for adults with acute leukemia and restrictive prophylactic platelet transfusion. Ann Hematol. 2003;82(9):570–3.

    Article  PubMed  Google Scholar 

  101. Rimondi E, Staals EL, Errani C, Bianchi G, Casadei R, Alberghini M, et al. Percutaneous CT-guided biopsy of the spine: results of 430 biopsies. Eur Spine J. 2008;17(7):975–81.

    Article  PubMed  PubMed Central  Google Scholar 

  102. Lynch SL, Boon AJ, Smith J, Harper Jr CM, Tanaka EM. Complications of needle electromyography: hematoma risk and correlation with anticoagulation and antiplatelet therapy. Muscle Nerve. 2008;38(4):1225–30.

    Article  PubMed  Google Scholar 

  103. Kumar N, Newman RJ. Complications of intra- and peri-articular steroid injections. Br J Gen Pract. 1999;49(443):465–6.

    CAS  PubMed  PubMed Central  Google Scholar 

  104. Szopinski KT, Smigielski R. Safety of sonographically guided aspiration of intramuscular, bursal, articular and subcutaneous hematomas. Eur J Radiol. 2012;81(7):1581–3.

    Article  PubMed  Google Scholar 

  105. Goz V, Errico TJ, Weinreb JH, Koehler SM, Hecht AC, Lafage V, et al. Vertebroplasty and kyphoplasty: national outcomes and trends in utilization from 2005 through 2010. Spine J. 2015;15(5):959–65.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiology, University Hospitals Case Medical Center, Cleveland, OH, USA

    Shiraz Rahim M.D., Indravadan J. Patel M.D. & Jon C. Davidson M.D.

Authors
  1. Shiraz Rahim M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Indravadan J. Patel M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jon C. Davidson M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jon C. Davidson M.D. .

Editor information

Editors and Affiliations

  1. Departments of Pathology & Immunology, Pediatrics, and Medicine, Baylor College of Medicine Division of Transfusion Medicine & Coagulation Texas Children’s Hospital, Houston, Texas, USA

    Jun Teruya

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Rahim, S., Patel, I.J., Davidson, J.C. (2016). Percutaneous Image-Guided Interventions Including Solid Organ Biopsies. In: Teruya, J. (eds) Management of Bleeding Patients. Springer, Cham. https://doi.org/10.1007/978-3-319-30726-8_30

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-30726-8_30

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-30724-4

  • Online ISBN: 978-3-319-30726-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation